Skip to main content

MoneyWorks4Me

Mercury Laboratories - Quaterly Results

06 Nov 2026 Evaluate
The revenue for the September 2026 quarter is pegged at Rs. 190.09 millions against Rs. 190.09 millions recorded during the year-ago period.Net profit of the cmpany stood at Rs. 6.73 millions for the quarter ended September 2026 a decline of -59.06% from Rs. 16.44 millions  in the same quarter last year.The Operating Profit of the company witnessed a decrease to 18.15 millions from 29.19 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202609 202509 % Var 202609 202509 % Var 202603 202503 % Var
Sales 190.09 190.09 0.00 349.72 371.44 -5.85 759.37 751.01 1.11
Other Income 3.78 7.91 -52.21 4.30 9.72 -55.76 19.55 10.69 82.88
PBIDT 18.15 29.19 -37.82 30.59 54.54 -43.91 109.96 80.85 36.00
Interest 1.62 1.32 22.73 2.85 2.77 2.89 5.45 5.48 -0.55
PBDT 16.53 27.87 -40.69 27.74 51.77 -46.42 100.56 75.37 33.42
Depreciation 7.37 8.63 -14.60 14.66 17.06 -14.07 34.20 28.76 18.92
PBT 9.16 19.24 -52.39 13.08 34.71 -62.32 66.36 46.61 42.37
TAX 2.43 2.80 -13.21 3.37 8.60 -60.81 18.03 15.16 18.93
Deferred Tax 0.13 -2.90 -104.48 -0.23 -1.90 -87.89 1.42 1.68 -15.48
PAT 6.73 16.44 -59.06 9.71 26.11 -62.81 48.33 31.45 53.67
Equity 12.00 12.00 0.00 12.00 12.00 0.00 12.00 12.00 0.00
PBIDTM(%) 9.55 15.36 -37.82 8.75 14.68 -40.43 14.48 10.77 34.51
Peers
Company Name CMP
Sun Pharma. Inds. 1915.10
Dr. Reddys Labs. 1369.00
Cipla 1410.95
Lupin 1995.00
Zydus Lifesciences 1200.00
View more..